Access Cannulation Trial II

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 23, 2025

Primary Completion Date

March 25, 2027

Study Completion Date

March 25, 2027

Conditions
Dialysis; ComplicationsVascular Access Complication
Interventions
DEVICE

VenaSure

The device will be surgically implanted at the access site in subjects undergoing routine hemodialysis. The device is expected to provide a target to aid in long-term cannulation success.

Trial Locations (7)

24014

RECRUITING

Fairlawn Surgery Center, Roanoke

29118

RECRUITING

MUSC Health Orangeburg, Orangeburg

36301

RECRUITING

Trinity Research Group, Dothan

75246

RECRUITING

Baylor Scott & White, Dallas

78756

RECRUITING

Cardiothoracic and Vascular Surgeons, Austin

92505

RECRUITING

Apex Research, Riverside

02115

RECRUITING

Brigham and Women's Hospital, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Voyager Biomedical

INDUSTRY

NCT05490225 - Access Cannulation Trial II | Biotech Hunter | Biotech Hunter